| Indicators | Browse All

Aclarion, Inc. (ACON)

Healthcare | Health Information Services | Broomfield, United States | NasdaqCM
1.94 USD -0.20 (-9.346%) ⇩ (Oct. 14, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:☆☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 3:39 a.m. EDT

The investment case for Aclarion is effectively extinguished by a catastrophic multi-year price collapse and deteriorating fundamentals. The stock has lost 99.99% of its value over the last three years, with every single year showing a massive decline, signaling a structural failure in the business model rather than a temporary market correction. Despite a 'strong buy' analyst recommendation and a high target price, these metrics are irrelevant given the negative earnings, negative free cash flow, and operating losses exceeding 100%. The company recently secured financing to extend its runway, which confirms that the current cash burn is unsustainable without further dilution. While there was a brief, sharp recovery in recent trading sessions, the underlying reality remains a failing enterprise with no reliable path to profitability or value restoration.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.202269
AutoETS0.203741
AutoTheta0.401716
MSTL0.869944

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 39%
H-stat 1.41
Ljung-Box p 0.000
Jarque-Bera p 0.201
Excess Kurtosis -0.21
Attribute Value
Sector Healthcare
Revenue per Share 0.057
Market Cap 5,591,800
Forward P/E -0.35
Beta 1.21
Previous Name Coin Gabbar
Website https://www.aclarion.com

Info Dump

Attribute Value
52 Week Change -0.7868132
Address1 8,181 Arista Place
Address2 Suite 100
All Time High 586,116.0
All Time Low 1.95
Ask 3.14
Ask Size 2
Average Analyst Rating 1.0 - Strong Buy
Average Daily Volume10 Day 25,540
Average Daily Volume3 Month 51,787
Average Volume 51,787
Average Volume10Days 25,540
Beta 1.206
Bid 1.78
Bid Size 2
Book Value 6.905
City Broomfield
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.94
Current Ratio 16.196
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 2.13
Day Low 1.8901
Display Name Aclarion
Dividend Yield 0.0
Ebitda -9,468,166
Ebitda Margins 0.0
Enterprise To Ebitda 1.13
Enterprise To Revenue -127.776
Enterprise Value -10,703,662
Eps Current Year -4.51
Eps Forward -5.47
Eps Trailing Twelve Months -7.38
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.4523
Fifty Day Average Change -0.5123
Fifty Day Average Change Percent -0.20890592
Fifty Two Week Change Percent -78.68132
Fifty Two Week High 9.38
Fifty Two Week High Change -7.44
Fifty Two Week High Change Percent -0.79317695
Fifty Two Week Low 1.89
Fifty Two Week Low Change 0.05000007
Fifty Two Week Low Change Percent 0.026455065
Fifty Two Week Range 1.89 - 9.38
Financial Currency USD
First Trade Date Milliseconds 1,650,634,200,000
Float Shares 2,520,432
Forward Eps -5.47
Forward P E -0.35466182
Free Cashflow -5,323,035
Full Exchange Name NasdaqCM
Full Time Employees 10
Fullday Change -0.20000005
Fullday Change Percent -9.345796
Fullday Price 1.94
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.21755
Gross Profits 18,224
Has Pre Post Market Data 1
Held Percent Insiders 0.23976
Held Percent Institutions 0.040009998
Implied Shares Outstanding 2,882,371
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,743,120,000
Last Split Factor 1:27
Long Business Summary Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Long Name Aclarion, Inc.
Market us_market
Market Cap 5,591,800
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_108179695
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-14
Net Income To Common -9,196,562
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 7,580,635
Number Of Analyst Opinions 2
Open 2.12
Operating Cashflow -8,086,706
Operating Margins -115.031815
Phone 833 275 2266
Prev Name Coin Gabbar
Previous Close 2.14
Price Eps Current Year -0.4301552
Price Hint 4
Price To Book 0.28095582
Price To Sales Trailing12 Months 66.75262
Profit Margins 0.0
Quick Ratio 15.742
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.0
Region US
Regular Market Change -0.20000005
Regular Market Change Percent -9.345796
Regular Market Day High 2.13
Regular Market Day Low 1.8901
Regular Market Day Range 1.8901 - 2.13
Regular Market Open 2.12
Regular Market Previous Close 2.14
Regular Market Price 1.94
Regular Market Time 1,792,008,000
Regular Market Volume 70,944
Return On Assets -0.37014
Return On Equity -0.58966
Revenue Growth 0.305
Revenue Per Share 0.057
Sand P52 Week Change 0.1570785
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 2,882,371
Shares Percent Shares Out 0.017
Shares Short 48,934
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 24,767
Short Name Aclarion, Inc.
Short Percent Of Float 0.017
Short Ratio 0.96
Source Interval 15
State CO
Symbol ACON
Target High Price 7.75
Target Low Price 7.5
Target Mean Price 7.625
Target Median Price 7.625
Total Cash 16,295,462
Total Cash Per Share 5.653
Total Debt 0
Total Revenue 83,769
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -7.38
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.04337
Two Hundred Day Average Change -1.10337
Two Hundred Day Average Change Percent -0.36254874
Type Disp Equity
Volume 70,944
Website https://www.aclarion.com
Zip 80,021